You are here:

Dantrolene sodium (Dantrium)

Other name: Dantrium

Dantrolene sodium is a drug used to treat chronic, severe spasticity and spasms. The NICE guideline states that dantrolene can be used if treatment with baclofen or gabapentin has not been successful.

How does dantrolene work?

Dantrolene works by stopping some electrical impulses travelling within muscles, thereby preventing muscle contractions. This contrasts with most other spasticity drugs that work by preventing or inhibiting the way the brain and spinal cord communicate through the nerves with the rest of the body.

How do I take dantrolene?

Dantrolene sodium is taken orally as tablets. Dosage varies but should not exceed 400mg per day.

Side effects and contraindications

Side effects include drowsiness, dizziness, weakness and fatigue. All of these may be temporary. Another side effect you may experience is diarrhoea, which can be severe. Dantrolene should not be taken by people with a history of liver dysfunction, or by pregnant or breastfeeding women.

Liver function tests should be carried out before starting and frequently during treatment as there is a risk of liver damage (known as hepatotoxicity).

More references

  • Shakespeare DT, et al. Anti-spasticity agents for multiple sclerosis. Cochrane Database of Systematic Reviews 2003;(4):CD001332. Summary
  • Otero-Romero S, et al. Pharmacological management of spasticity in multiple sclerosis: systematic review and consensus paper. Multiple Sclerosis Journal 2016;22(11):1386–1396 Summary

Last updated: January 2018
Last reviewed: January 2018
This page will be reviewed within three years

More references

  • Shakespeare DT, et al. Anti-spasticity agents for multiple sclerosis. Cochrane Database of Systematic Reviews 2003;(4):CD001332. Summary
  • Otero-Romero S, et al. Pharmacological management of spasticity in multiple sclerosis: systematic review and consensus paper. Multiple Sclerosis Journal 2016;22(11):1386–1396 Summary

Print this page

Rate this page:

Fieldset
*Any personal information will not be followed up or be given to third parties.
*Any personal information will not be followed up or be given to third parties.
*Any personal information will not be followed up or be given to third parties.
*Any personal information will not be followed up or be given to third parties.
*Any personal information will not be followed up or be given to third parties.

Please fill in the fields below if you would like to stay in touch with the MS Trust to help with further testing and feedback on the MS Trust website

Do you have a question about MS? Contact our enquiry team